Seek Returns logo

CNC vs. QGEN: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at CNC and QGEN, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolCNCQGEN
Company NameCentene CorporationQiagen N.V.
CountryUnited StatesNetherlands
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Providers & ServicesLife Sciences Tools & Services
Market Capitalization19.01 billion USD10.15 billion USD
ExchangeNYSENYSE
Listing DateDecember 13, 2001June 28, 1996
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of CNC and QGEN by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CNC vs. QGEN: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolCNCQGEN
5-Day Price Return9.91%6.51%
13-Week Price Return16.18%-3.19%
26-Week Price Return-36.25%16.56%
52-Week Price Return-46.71%5.52%
Month-to-Date Return8.46%4.74%
Year-to-Date Return-36.12%5.10%
10-Day Avg. Volume11.35M1.09M
3-Month Avg. Volume14.49M1.40M
3-Month Volatility50.29%23.36%
Beta0.470.68

Profitability

Return on Equity (TTM)

CNC

7.53%

Health Care Providers & Services Industry

Max
24.86%
Q3
15.79%
Median
8.56%
Q1
5.75%
Min
-1.64%

CNC’s Return on Equity of 7.53% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

QGEN

10.66%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.51%
Median
6.47%
Q1
3.86%
Min
-6.95%

QGEN’s Return on Equity of 10.66% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

CNC vs. QGEN: A comparison of their Return on Equity (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

CNC

1.15%

Health Care Providers & Services Industry

Max
11.56%
Q3
5.45%
Median
2.83%
Q1
1.13%
Min
-1.71%

CNC’s Net Profit Margin of 1.15% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

QGEN

18.30%

Life Sciences Tools & Services Industry

Max
32.18%
Q3
18.30%
Median
10.19%
Q1
4.20%
Min
-2.05%

QGEN’s Net Profit Margin of 18.30% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

CNC vs. QGEN: A comparison of their Net Profit Margin (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

CNC

1.08%

Health Care Providers & Services Industry

Max
19.08%
Q3
9.66%
Median
4.77%
Q1
2.46%
Min
-0.83%

CNC’s Operating Profit Margin of 1.08% is in the lower quartile for the Health Care Providers & Services industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

QGEN

22.84%

Life Sciences Tools & Services Industry

Max
38.39%
Q3
21.40%
Median
13.57%
Q1
8.38%
Min
-3.51%

An Operating Profit Margin of 22.84% places QGEN in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

CNC vs. QGEN: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolCNCQGEN
Return on Equity (TTM)7.53%10.66%
Return on Assets (TTM)2.43%6.40%
Net Profit Margin (TTM)1.15%18.30%
Operating Profit Margin (TTM)1.08%22.84%
Gross Profit Margin (TTM)8.93%64.18%

Financial Strength

Current Ratio (MRQ)

CNC

1.10

Health Care Providers & Services Industry

Max
2.00
Q3
1.51
Median
1.29
Q1
0.92
Min
0.14

CNC’s Current Ratio of 1.10 aligns with the median group of the Health Care Providers & Services industry, indicating that its short-term liquidity is in line with its sector peers.

QGEN

1.61

Life Sciences Tools & Services Industry

Max
3.46
Q3
2.78
Median
1.91
Q1
1.53
Min
0.43

QGEN’s Current Ratio of 1.61 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

CNC vs. QGEN: A comparison of their Current Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

CNC

0.64

Health Care Providers & Services Industry

Max
2.29
Q3
1.24
Median
0.74
Q1
0.50
Min
0.00

CNC’s Debt-to-Equity Ratio of 0.64 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

QGEN

0.41

Life Sciences Tools & Services Industry

Max
1.35
Q3
0.74
Median
0.41
Q1
0.18
Min
0.00

QGEN’s Debt-to-Equity Ratio of 0.41 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

CNC vs. QGEN: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

CNC

7.06

Health Care Providers & Services Industry

Max
14.47
Q3
7.50
Median
4.52
Q1
2.12
Min
-4.44

CNC’s Interest Coverage Ratio of 7.06 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.

QGEN

27.84

Life Sciences Tools & Services Industry

Max
45.00
Q3
27.84
Median
7.16
Q1
2.12
Min
-14.08

QGEN’s Interest Coverage Ratio of 27.84 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

CNC vs. QGEN: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolCNCQGEN
Current Ratio (MRQ)1.101.61
Quick Ratio (MRQ)1.101.20
Debt-to-Equity Ratio (MRQ)0.640.41
Interest Coverage Ratio (TTM)7.0627.84

Growth

Revenue Growth

CNC vs. QGEN: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

CNC vs. QGEN: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

CNC

0.00%

Health Care Providers & Services Industry

Max
5.93%
Q3
2.59%
Median
1.35%
Q1
0.00%
Min
0.00%

CNC currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

QGEN

0.00%

Life Sciences Tools & Services Industry

Max
1.41%
Q3
0.65%
Median
0.35%
Q1
0.00%
Min
0.00%

QGEN currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

CNC vs. QGEN: A comparison of their Dividend Yield (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

CNC

0.00%

Health Care Providers & Services Industry

Max
185.33%
Q3
74.82%
Median
36.00%
Q1
0.00%
Min
0.00%

CNC has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

QGEN

0.00%

Life Sciences Tools & Services Industry

Max
113.14%
Q3
61.34%
Median
17.74%
Q1
0.00%
Min
0.00%

QGEN has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

CNC vs. QGEN: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolCNCQGEN
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

CNC

9.13

Health Care Providers & Services Industry

Max
40.02
Q3
29.75
Median
21.09
Q1
14.18
Min
7.05

In the lower quartile for the Health Care Providers & Services industry, CNC’s P/E Ratio of 9.13 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

QGEN

27.10

Life Sciences Tools & Services Industry

Max
75.35
Q3
51.00
Median
32.93
Q1
25.27
Min
1.43

QGEN’s P/E Ratio of 27.10 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

CNC vs. QGEN: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

CNC

0.11

Health Care Providers & Services Industry

Max
3.15
Q3
1.87
Median
0.74
Q1
0.27
Min
0.09

In the lower quartile for the Health Care Providers & Services industry, CNC’s P/S Ratio of 0.11 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

QGEN

4.96

Life Sciences Tools & Services Industry

Max
10.49
Q3
6.43
Median
4.66
Q1
2.88
Min
1.08

QGEN’s P/S Ratio of 4.96 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

CNC vs. QGEN: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

CNC

0.99

Health Care Providers & Services Industry

Max
7.33
Q3
4.45
Median
2.52
Q1
1.15
Min
0.66

CNC’s P/B Ratio of 0.99 is in the lower quartile for the Health Care Providers & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

QGEN

2.97

Life Sciences Tools & Services Industry

Max
6.69
Q3
5.00
Median
3.46
Q1
2.38
Min
0.93

QGEN’s P/B Ratio of 2.97 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

CNC vs. QGEN: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolCNCQGEN
Price-to-Earnings Ratio (TTM)9.1327.10
Price-to-Sales Ratio (TTM)0.114.96
Price-to-Book Ratio (MRQ)0.992.97
Price-to-Free Cash Flow Ratio (TTM)6.3520.40